ResMed Inc (RMD) - Total Liabilities
Based on the latest financial reports, ResMed Inc (RMD) has total liabilities worth $2.18 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore RMD cash generation efficiency to assess how effectively this company generates cash.
ResMed Inc - Total Liabilities Trend (1993–2025)
This chart illustrates how ResMed Inc's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of ResMed Inc to evaluate the company's liquid asset resilience ratio.
ResMed Inc Competitors by Total Liabilities
The table below lists competitors of ResMed Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Prudential plc
F:PRU2
|
Germany | €179.68 Billion |
|
United Airlines Holdings Inc
NASDAQ:UAL
|
USA | $61.17 Billion |
|
Iron Mountain Incorporated
NYSE:IRM
|
USA | $21.24 Billion |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
SHE:300760
|
China | CN¥15.02 Billion |
|
PTT Public Company Limited
F:NVA3
|
Germany | €1.67 Trillion |
|
Arch Capital Group Ltd
F:RSK
|
Germany | €55.47 Billion |
|
Celltrion Inc
KO:068270
|
Korea | ₩4.98 Trillion |
|
China State Construction Engineering Corp Ltd
SHG:601668
|
China | CN¥2.60 Trillion |
Liability Composition Analysis (1993–2025)
This chart breaks down ResMed Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RMD market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.14 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ResMed Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ResMed Inc (1993–2025)
The table below shows the annual total liabilities of ResMed Inc from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $2.21 Billion | +9.87% |
| 2024-06-30 | $2.01 Billion | -23.40% |
| 2023-06-30 | $2.62 Billion | +51.10% |
| 2022-06-30 | $1.74 Billion | -5.83% |
| 2021-06-30 | $1.84 Billion | -11.86% |
| 2020-06-30 | $2.09 Billion | +2.70% |
| 2019-06-30 | $2.04 Billion | +102.55% |
| 2018-06-30 | $1.00 Billion | -33.37% |
| 2017-06-30 | $1.51 Billion | -3.57% |
| 2016-06-30 | $1.56 Billion | +162.01% |
| 2015-06-30 | $596.95 Million | -0.96% |
| 2014-06-30 | $602.71 Million | +0.42% |
| 2013-06-30 | $600.21 Million | +13.19% |
| 2012-06-30 | $530.24 Million | +56.79% |
| 2011-06-30 | $338.19 Million | -0.20% |
| 2010-06-30 | $338.86 Million | -13.73% |
| 2009-06-30 | $392.78 Million | +21.14% |
| 2008-06-30 | $324.23 Million | +1.06% |
| 2007-06-30 | $320.82 Million | +19.23% |
| 2006-06-30 | $269.07 Million | -10.33% |
| 2005-06-30 | $300.08 Million | +59.91% |
| 2004-06-30 | $187.65 Million | +8.37% |
| 2003-06-30 | $173.16 Million | -5.51% |
| 2002-06-30 | $183.26 Million | -2.38% |
| 2001-06-30 | $187.72 Million | +768.21% |
| 2000-06-30 | $21.62 Million | +18.22% |
| 1999-06-30 | $18.29 Million | +32.53% |
| 1998-06-30 | $13.80 Million | +33.98% |
| 1997-06-30 | $10.30 Million | +24.10% |
| 1996-06-30 | $8.30 Million | +29.69% |
| 1995-06-30 | $6.40 Million | +60.00% |
| 1994-06-30 | $4.00 Million | +73.91% |
| 1993-06-30 | $2.30 Million | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more